Support for the continuation of an ongoing project in collaboration with the Tor Vergato University of Rome, which has given the first satisfactory results; now it will be developed on a more representative sample and, above all, aimed at identifying one or more components of Lactoferrin which, at physiological concentrations, are capable of preventing infections (also from Covid-19) in the early stages and hence use them to fine-tune targeted treatments.